Study on bronchus expansion effect on COPD patient of glycopyrronium bromide

Study on bronchus expansion effect on COPD patient of glycopyrronium bromide - Study on bronchus expansion effect on COPD patient

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011848

Enrollment

Registered

2013-09-24

Start date

2013-03-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Interventions

Inhalation of a glycopyrronium bromide

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The adult aged 40 and over with this smoking history by which center visitor going to hospital regularly is carried out. The patient who corresponds to a COPD 1 term and 2 term in a respiratory function test

Exclusion criteria

Exclusion criteria: The patient whom the examination responsibility (assignment) doctor judged to be unsuitable as a subject is excluded. Lung tumor or the case in which a metastatic pulmonary tumor was accepted is excepted.

Design outcomes

Primary

Measure	Time frame
The rate of change of medical treatment start before of 3rd the 6th airway area (mm2) in three-dimensional respiratory tract analysis software, and two weeks after	—

Secondary

Measure	Time frame
The amount of change of 3rd the 6th airway area in three-dimensional respiratory tract analysis software The difference of the amount of change of a COPD assessment test	—

Countries

Japan

Contacts

Public Contactsatoru ishii

national center for global health and medicine respiratory department

satishii@hosp.ncgm.go.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026